| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |